Nuvalent (NUVL) Tax Provisions (2024 - 2026)
Nuvalent (NUVL) posted Tax Provisions of $168000.0 for Q1 2026, up 100.19% on a QoQ basis from -$89.6 million in Q4 2025, and up 7.01% year-over-year from $157000.0 in Q1 2025.
Nuvalent (NUVL) Tax Provisions (2024 - 2026) Analysis & Trends
Nuvalent's Tax Provisions history runs 3 years deep, the most recent figure standing at $168000.0 for Q1 2026.
- Quarterly Tax Provisions rose 7.01% year-over-year to $168000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$89.2 million (down 16679.0% YoY) and the FY2025 annual result came in at -$89.2 million, down 11776.18% from the prior year.
- Tax Provisions was $168000.0 for Q1 2026 at Nuvalent, up from -$89.6 million in the prior quarter.
- Across five years, Tax Provisions topped out at $383000.0 in Q1 2024 and bottomed at -$89.6 million in Q4 2025.
- A 3-year average of -$9.8 million and a median of $157000.0 in 2025 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 230.0% in 2025, while the deepest fall reached 52521.05% in 2025.
- Nuvalent's Tax Provisions stood at $171000.0 in 2024, then tumbled by 52521.05% to -$89.6 million in 2025, then soared by 100.19% to $168000.0 in 2026.
- Business Quant data shows NUVL's Tax Provisions at $168000.0 in Q1 2026, -$89.6 million in Q4 2025, and $132000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168,000.00 |
| Dec 31, 2025 | -89.64 Mn |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 145,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 383,000.00 |